RNA methylation: A new perspective in osteoarthritis research
Related Experiment Video
Updated: May 12, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Guihao Zheng1, Meifeng Lu1, Yulong Ouyang2
1Department of Sports Medicine, Orthopaedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China; Graduate School of Jiangxi Medical College, Nanchang University, China.
Abstract:
Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by cartilage degradation, osteophyte formation, and joint dysfunction, significantly impairing the quality of life in the elderly population. Recently, RNA modifications, as a dynamic and reversible epigenetic modification, have emerged as critical players in the onset and progression of OA. This review systematically summarizes the major types of RNA modifications involved in OA, including N6-methyladenosine (m6A), 5-methylcytosine (m5C), and 7-methylguanosine (m7G), and explores their roles in regulating chondrocyte autophagy, inflammatory responses, and key signaling pathways. with a primary focus on RNA methylation. Special emphasis is placed on the dynamic regulatory functions of key methyltransferases (e.g., METTL3, FTO, WTAP) and their potential contributions to OA pathogenesis. Furthermore, we address current research hotspots and controversies in the field, proposing future research directions, such as leveraging single-cell sequencing to decipher dynamic RNA modification changes during OA progression and uncovering the cooperative networks among various RNA modifications. Advancing our understanding of the biological roles and mechanisms of RNA modifications holds promise for innovative strategies in the early diagnosis, disease stratification, and targeted therapy of OA.
Insights
RNA modifications, like N6-methyladenosine (m6A), are crucial in osteoarthritis (OA) development. Understanding these epigenetic changes and methyltransferases offers new avenues for OA diagnosis and treatment.
Area of Science:
- Epigenetics
- Molecular Biology
- Rheumatology
Background:
- Osteoarthritis (OA) is a degenerative joint disease impacting elderly quality of life.
- RNA modifications are emerging as key epigenetic regulators in OA pathogenesis.
- This review focuses on RNA methylation's role in OA.
Purpose of the Study:
- To systematically review RNA modifications (m6A, m5C, m7G) in OA.
- To explore their regulatory roles in chondrocyte autophagy, inflammation, and signaling pathways.
- To highlight the function of methyltransferases in OA.
Main Methods:
- Systematic literature review.
- Analysis of RNA modification types and their functions.
- Focus on methyltransferases (METTL3, FTO, WTAP) and OA pathogenesis.
Main Results:
- RNA modifications, particularly m6A, play significant roles in OA.
- Methyltransferases dynamically regulate processes involved in OA.
- Current research highlights hotspots and controversies in the field.
Conclusions:
- Understanding RNA modifications offers potential for OA early diagnosis and targeted therapies.
- Future research should explore single-cell sequencing for dynamic changes and cooperative networks.
- Deciphering RNA modification mechanisms is key for innovative OA strategies.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

